Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio-Techne Corp TECH

Healthcare  —  Biotechnology
72.61 0.04 0.06% as of 25 Sep
Market cap
$11.4B
P/E
62.1×
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bio-Techne Corp (TECH) EV/EBITDA

As of 25 September 2026, Bio-Techne Corp (TECH) trades at a EV/EBITDA of 32.3×. Over the past ten years it has ranged from 16.7× (January 2016) to 64.6× (September 2021); the current reading is higher than 49% of that period. That is above the Biotechnology industry median of 0.7× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2026 31.4× (19.74%)
FY2025 39.1× 8.59%
FY2024 36.0× 12.68%
FY2023 32.0× (6.53%)
FY2022 34.2× (36.66%)
FY2021 54.0× 27.50%
FY2020 42.4× 15.54%
FY2019 36.7× 28.78%
FY2018 28.5× 12.50%
FY2017 25.3× 16.80%

Quarterly

Period EV/EBITDA Change
Jun 2026 31.4× (2.37%)
Mar 2026 32.2× (23.38%)
Dec 2025 42.0× 2.87%
Sep 2025 40.8× 4.30%
42 more quarters

Against its own ten years

Low 16.7× High 64.6×
Ten-year median 32.4×
Current reading's percentile 49

EV/EBITDA against peers

Company EV/EBITDA
BBIO BridgeBio Pharma, Inc. compare n/m
MDGL Madrigal Pharmaceuticals, Inc. compare n/m
SMMT Summit Therapeutics PLC compare n/m
AXSM Axsome Therapeutics, Inc. compare n/m
HALO Halozyme Therapeutics, Inc. compare 21.2×
TECH Bio-Techne Corp 32.3×
KRYS Krystal Biotech, Inc. compare 45.9×
BMRN BioMarin Pharmaceutical Inc. compare 50.3×
CORT Corcept Therapeutics Incorporated compare 3,206×
Biotechnology industry median 0.7×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on TECH